Comments for HLCS - Stockpickr! Your Source for Stock Ideas

Comments for HLCS

Added By	Comments	Type	Date Added
barrons2	Neutral - Price 6 on March 19 by UBS Investment Research [Helicos makes the HeliScope, a genetic analyzer/integrated gene-sequencing instrument.] HLCS shares have declined [by more than] 40% [year-to-date], as concerns over increased competition, unexpected management changes, slow commercial rollout, and a high '08 cash burn forecast have outweighed its modest progress since the May 2007 [initial public offering]. Although we still have lingering concerns regarding HLCS' ability to execute and have lowered our sales forecasts, we upgrade [our rating] to Neutral from Sell chiefly on valuation following the pullback. HLCS recently shipped its first HeliScope, a key positive milestone...[yet] given the HeliScope's $1.35 million price tag, significant customer validation will be needed to spur broad uptake...HLCS has little room for further delays. HLCS guides for $40 million to $50 million cash burn in '08...Our new target, 6.50 (was 10.50), is based on a [discounted-cash-flow] analysis. Market-cap: $125 million.	Love	March 22, 2008
drifter2475	it was new.	Love	October 31, 2007